Company intelligence / Profile preview

Terumo

Shibuya-ku, Tokyo, Japanterumo.com ↗

Ownership: Private
Employees: ~30000
Development stage: Commercial

Overview

Terumo has a century-long track record of innovation in medical devices. Its current portfolio includes globally commercialized products for vascular intervention/cardiac surgery/neurovascular procedures/blood component collection and processing/cell therapy technologies/diabetes care/peritoneal dialysis. The company’s solutions are widely adopted in clinical practice worldwide.

Therapeutic areas: OncologyEndocrinologyHematologyCardiovascularNeurology
Modalities: DeviceBiologicSmall molecule
Industry: Therapeutic Medical Devices

Partnerships

Major collaborations with hospitals/universities for clinical researchDistribution agreements with companies like Pall Corporation for filtersJoint ventures such as Penpol in India

Beyond the preview

Go deeper on Terumo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Terumo.

Explore the full profile